nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acquired and Congenital Risk Factors associated with Cerebral Venous Sinus Thrombosis
|
McBane II, Robert D. |
|
2010 |
126 |
2 |
p. 81-87 7 p. |
artikel |
2 |
Antiplatelet effects of antidepressant treatment: A randomized comparison between escitalopram and nortriptyline
|
Flöck, Anne |
|
2010 |
126 |
2 |
p. e83-e87 nvt p. |
artikel |
3 |
A potential regulatory role for mRNA secondary structures within the prothrombin 3'UTR
|
Liu, Xingge |
|
2010 |
126 |
2 |
p. 130-136 7 p. |
artikel |
4 |
Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: A case report
|
Godier, Anne |
|
2010 |
126 |
2 |
p. e141-e143 nvt p. |
artikel |
5 |
Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women
|
Hussein, Ayman S. |
|
2010 |
126 |
2 |
p. e78-e82 nvt p. |
artikel |
6 |
Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency
|
Corno, Anna Rosa |
|
2010 |
126 |
2 |
p. e152-e153 nvt p. |
artikel |
7 |
Autopsy case of antithrombin producing in hepatocellular carcinoma
|
Ochiai, Yasuo |
|
2010 |
126 |
2 |
p. e157-e158 nvt p. |
artikel |
8 |
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP
|
Lombardi, Anna Maria |
|
2010 |
126 |
2 |
p. e154-e156 nvt p. |
artikel |
9 |
Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: A pilot study
|
Schroeder, Verena |
|
2010 |
126 |
2 |
p. e122-e127 nvt p. |
artikel |
10 |
Coexisting dysfibrinogenemia (γArg275His) and FV Leiden associated with thrombosis (Fibrinogen Crete)
|
Travlou, A. |
|
2010 |
126 |
2 |
p. e162-e164 nvt p. |
artikel |
11 |
Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content
|
Rábai, Gyöngyi |
|
2010 |
126 |
2 |
p. e94-e101 nvt p. |
artikel |
12 |
Development and preliminary evaluation of the KIDCLOT PAC QL©: A new health-related quality of life measure for pediatric long-term anticoagulation therapy
|
Bruce, A.A.K. |
|
2010 |
126 |
2 |
p. e116-e121 nvt p. |
artikel |
13 |
Editorial Board
|
|
|
2010 |
126 |
2 |
p. IFC- 1 p. |
artikel |
14 |
EMPoWarMENT: Edmonton Pediatric Warfarin Self-Management Pilot Study in Children with Primarily Cardiac Disease
|
Bauman, M.E. |
|
2010 |
126 |
2 |
p. e110-e115 nvt p. |
artikel |
15 |
Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection
|
Laine, Outi |
|
2010 |
126 |
2 |
p. 154-158 5 p. |
artikel |
16 |
Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke
|
Shemirani, Amir H. |
|
2010 |
126 |
2 |
p. 159-162 4 p. |
artikel |
17 |
Haemostatic profile of healthy premature small for gestational age neonates
|
Mitsiakos, George |
|
2010 |
126 |
2 |
p. 103-106 4 p. |
artikel |
18 |
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
|
Connolly, Gregory C. |
|
2010 |
126 |
2 |
p. 113-118 6 p. |
artikel |
19 |
Lupus Anticoagulant-Hypoprothrombinemia syndrome (HLAS): Report of one case in a familial infectious context
|
Appert-Flory, A. |
|
2010 |
126 |
2 |
p. e139-e140 nvt p. |
artikel |
20 |
Magnetic resonance imaging and ultrasonography in diagnosis of pelvic vein thrombosis during pregnancy
|
Torkzad, Michael R. |
|
2010 |
126 |
2 |
p. 107-112 6 p. |
artikel |
21 |
Microscopic clot fragment evidence of biochemo-mechanical degradation effects in thrombolysis
|
Bajd, Franci |
|
2010 |
126 |
2 |
p. 137-143 7 p. |
artikel |
22 |
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients
|
Viuff, Dorthe |
|
2010 |
126 |
2 |
p. 144-149 6 p. |
artikel |
23 |
Pediatric warfarin practice and pharmacogenetic testing
|
Thornburg, Courtney D. |
|
2010 |
126 |
2 |
p. e144-e146 nvt p. |
artikel |
24 |
Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation
|
Vazquez, Sara R. |
|
2010 |
126 |
2 |
p. e69-e77 nvt p. |
artikel |
25 |
Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: A prospective observational study
|
Ternström, Lisa |
|
2010 |
126 |
2 |
p. e128-e133 nvt p. |
artikel |
26 |
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
|
Pengo, V. |
|
2010 |
126 |
2 |
p. 150-153 4 p. |
artikel |
27 |
Prevalence of Factor IX-R338L (Factor IX Padua) in a cohort of patients with venous thromboembolism and mild elevation of factor IX levels
|
Mazetto, Bruna de Moraes |
|
2010 |
126 |
2 |
p. e165- 1 p. |
artikel |
28 |
Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment
|
Harlev, Dan |
|
2010 |
126 |
2 |
p. 93-97 5 p. |
artikel |
29 |
Reducing agents induce thrombomodulin shedding in human endothelial cells
|
Menschikowski, Mario |
|
2010 |
126 |
2 |
p. e88-e93 nvt p. |
artikel |
30 |
Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention
|
Mokhtar, Omar Ait |
|
2010 |
126 |
2 |
p. e147-e149 nvt p. |
artikel |
31 |
Seasonal variation in the incidence of superficial venous thrombophlebitis
|
Kakkos, Stavros K. |
|
2010 |
126 |
2 |
p. 98-102 5 p. |
artikel |
32 |
Severe arterial thrombosis in a family with type III protein S deficiency caused by a frameshift mutation in the PROS1 gene
|
Larsen, Torben Bjerregaard |
|
2010 |
126 |
2 |
p. e159-e161 nvt p. |
artikel |
33 |
Standardized antigen preparation to achieve comparability of anti-β2-glycoprotein I assays
|
Müller, Carolin |
|
2010 |
126 |
2 |
p. e102-e109 nvt p. |
artikel |
34 |
Synergistic effect of a factor Xa inhibitor, TAK-442, and antiplatelet agents on whole blood coagulation and arterial thrombosis in rats
|
Konishi, Noriko |
|
2010 |
126 |
2 |
p. 124-129 6 p. |
artikel |
35 |
The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring
|
Harrison, Paul |
|
2010 |
126 |
2 |
p. e137-e138 nvt p. |
artikel |
36 |
The “normal” factor VIII concentration in plasma
|
Butenas, Saulius |
|
2010 |
126 |
2 |
p. 119-123 5 p. |
artikel |
37 |
The VKORC1 promoter is occupied by c-Myc transcription factor in HepG2 cells
|
Pfister, Anna |
|
2010 |
126 |
2 |
p. e150-e151 nvt p. |
artikel |
38 |
Use of the Delphi method to establish guidelines for treatment of thrombosis
|
Paikin, Jeremy |
|
2010 |
126 |
2 |
p. 79-80 2 p. |
artikel |
39 |
Use of the Delphi method to facilitate antithrombotics prescription during pregnancy
|
Chauleur, Celine |
|
2010 |
126 |
2 |
p. 88-92 5 p. |
artikel |
40 |
VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis
|
Pasmant, Eric |
|
2010 |
126 |
2 |
p. e134-e136 nvt p. |
artikel |